AR048001A1 - Hidroxi - 6 - fenilantridinas que contienen tio con actividad inhibitoria de pde4 y composiciones farmaceuticas que las contienen para el tratamiento de trastornos respiratorios. - Google Patents
Hidroxi - 6 - fenilantridinas que contienen tio con actividad inhibitoria de pde4 y composiciones farmaceuticas que las contienen para el tratamiento de trastornos respiratorios.Info
- Publication number
- AR048001A1 AR048001A1 ARP050100916A ARP050100916A AR048001A1 AR 048001 A1 AR048001 A1 AR 048001A1 AR P050100916 A ARP050100916 A AR P050100916A AR P050100916 A ARP050100916 A AR P050100916A AR 048001 A1 AR048001 A1 AR 048001A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- hydrogen
- alkoxy
- fluorine
- accordance
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Compuestos de formula (1), en donde R1, R2, R3, R31, R4, R5, R6 y R7 tienen los significados indicados en la que exhiben actividad inhibidora de PDE4 y son utiles en el tratamiento de trastornos respiratorios. Reivindicacion 1: Compuestos caracterizados porque responden a la formula (1), en donde: R1 es hidroxilo, C1-4-alcoxi, C3-7-cicloalcoxi, C3-7-cicloalquilmetoxi, 2,2-difluoroetoxi, o C1-4-alcoxi completamente o predominantemente sustituido por fluor; R2 es hidroxilo, C1-4- alcoxi, C3-7-cicloalcoxi, C3-7-cicloalquilmetoxi, 2,2-difluoroetoxi, o C1-4-alcoxi completamente o predominantemente sustituido por fluor; o en donde, R1 y R2 juntos son un grupo C1-2-alquilendioxi; R3 es hidrogeno o C1-4-alquilo; R31 es hidrogeno o C1-4-alquilo, ya sea, en una primera realizacion (realizacion a) de acuerdo con la presente; R4 es -O-R41, en donde, R41 es hidrogeno, C1-4-alquilo, C1-4-alcoxi-C1-4-alquilo, hidroxi-C2-4-alquilo, C1-7-alquilcarbonilo, o C1-4-alquilo completamente o predominantemente sustituido por fluor; y R5 es hidrogeno o C1-4-alquilo; o, en una segunda realizacion (realizacion b) de acuerdo con la presente; R4 es hidrogeno o C1-4-alquilo; y R5 es -O-R51, en donde, R51 es hidrogeno, C1-4-alquilo, C1-4-alcoxi- C1-4-alquilo, hidroxi-C2-4-alquilo, C1-7-alquilcarbonilo, o C1-4-alquilo completamente o predominantemente sustituido por fluor; R6 es hidrogeno, halogeno, C1-4-alquilo o C1-4-alcoxi, en un primer (aspecto 1) de acuerdo con la presente; R7 es - S(O)2N(R8)R9, en donde, R8 es hidrogeno, C1-4-alquilo, C1-4-alcoxi-C2-4-alquilo o C3-7-cicloalquilo; R9 es hidrogeno, C1-4-alquilo o C1-4-alcoxi-C2-4-alquilo, o R8 y R9 juntos e incluyendo el átomo de nitrogeno al que están unidos, forman un anillo heterociclo Het1, en donde, Het1 está opcionalmente sustituido por R81, y es un radical de anillo heterocíclico saturado de 3 a 7 miembros que corresponde el átomo de nitrogeno, al cual R8 y R9 están unidos, y opcionalmente un heteroátomo adicional seleccionado del grupo que consiste de oxígeno, nitrogeno y sulfuro, en donde, R81 es C1-4-alquilo; o, en un segundo aspecto (aspecto 2) de acuerdo con esta presente; R7 es -A-N(R10)S(O)2-R11, en donde, A es un enlace o C1-4-alquileno; R10 es hidrogeno o C1-4-alquilo; R11 es C1-4-alquilo, o fenilo R111-sustituido, en donde R111 es halogeno o C1-4-alquilo; o en un tercer aspecto (aspecto 3) de acuerdo con la presente; R7 es -S(O)nR12, en donde, n es 0, 1 o 2, R12 es C1-4-alquilo, y las sales, los N-oxidos y las sales de los N-oxidos de estos compuestos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04100988 | 2004-03-10 | ||
EP05100692 | 2005-02-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR048001A1 true AR048001A1 (es) | 2006-03-15 |
Family
ID=34961402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050100916A AR048001A1 (es) | 2004-03-10 | 2005-03-10 | Hidroxi - 6 - fenilantridinas que contienen tio con actividad inhibitoria de pde4 y composiciones farmaceuticas que las contienen para el tratamiento de trastornos respiratorios. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20080161339A1 (es) |
EP (1) | EP1725533A1 (es) |
JP (1) | JP2007527900A (es) |
KR (1) | KR20060124783A (es) |
AR (1) | AR048001A1 (es) |
AU (1) | AU2005221831A1 (es) |
BR (1) | BRPI0508473A (es) |
CA (1) | CA2558390A1 (es) |
IL (1) | IL177499A0 (es) |
NO (1) | NO20064416L (es) |
TW (1) | TW200540159A (es) |
WO (1) | WO2005087744A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7423046B2 (en) | 2002-08-29 | 2008-09-09 | Nycomed Gmbh | 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
WO2005077906A1 (en) | 2004-02-18 | 2005-08-25 | Altana Pharma Ag | Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors |
AR049419A1 (es) * | 2004-03-03 | 2006-08-02 | Altana Pharma Ag | Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo |
AU2005219576B2 (en) | 2004-03-03 | 2011-06-30 | Takeda Gmbh | Novel hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors |
NZ549254A (en) * | 2004-03-10 | 2010-06-25 | Nycomed Gmbh | Amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors |
PT1856093E (pt) | 2005-03-02 | 2010-02-08 | Nycomed Gmbh | Sal hcl de (2r,4ar,10br)-6-(2,6-dimetoxipiridin-3-il)-9-etoxi- 8-metoxi-1,2,3,4,4a,10b-hexa-hidrofenantridin-2-ol |
GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
MX2009004715A (es) | 2006-10-30 | 2009-05-20 | Novartis Ag | Compuestos heterociclicos como agentes antiinflamatorios. |
MX2010003155A (es) | 2007-10-04 | 2010-04-01 | Hoffmann La Roche | Derivados de ciclopropil aril amida y uso de los mismos. |
AU2009203693B2 (en) | 2008-01-11 | 2012-06-07 | Novartis Ag | Pyrimidines as kinase inhibitors |
US8637516B2 (en) | 2010-09-09 | 2014-01-28 | Irm Llc | Compounds and compositions as TRK inhibitors |
WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
EA201391230A1 (ru) | 2011-02-25 | 2014-01-30 | АйАрЭм ЭлЭлСи | Соединения и композиции в качестве ингибиторов trk |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI0882021T1 (en) * | 1996-01-31 | 2003-10-31 | Altana Pharma Ag | New phenanthridines |
US6127378A (en) * | 1996-03-26 | 2000-10-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridines substituted in the 6 position |
WO1997035854A1 (de) * | 1996-03-26 | 1997-10-02 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue in 6-position substituierte phenanthridine |
PT998460E (pt) * | 1997-07-25 | 2004-07-30 | Altana Pharma Ag | Novos derivados de tetrazole |
HUP0003311A3 (en) * | 1997-07-25 | 2002-10-28 | Altana Pharma Ag | Substituted 6-phenylphenanthridine derivatives, pocess for producing them and pharmaceutical compositions containing them |
DE59904535D1 (de) * | 1998-05-05 | 2003-04-17 | Altana Pharma Ag | Neue Benzonaphtyridin-N-oxide |
SK286946B6 (sk) * | 1999-01-15 | 2009-08-06 | Nycomed Gmbh | Fenylfenantridínové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie |
WO2004019944A1 (en) * | 2002-08-29 | 2004-03-11 | Altana Pharma Ag | 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
-
2005
- 2005-03-09 JP JP2007502342A patent/JP2007527900A/ja not_active Withdrawn
- 2005-03-09 US US10/591,768 patent/US20080161339A1/en not_active Abandoned
- 2005-03-09 KR KR1020067020591A patent/KR20060124783A/ko not_active Application Discontinuation
- 2005-03-09 AU AU2005221831A patent/AU2005221831A1/en not_active Abandoned
- 2005-03-09 WO PCT/EP2005/051052 patent/WO2005087744A1/en active Application Filing
- 2005-03-09 BR BRPI0508473-3A patent/BRPI0508473A/pt not_active IP Right Cessation
- 2005-03-09 EP EP05716969A patent/EP1725533A1/en not_active Withdrawn
- 2005-03-09 CA CA002558390A patent/CA2558390A1/en not_active Abandoned
- 2005-03-10 TW TW094107371A patent/TW200540159A/zh unknown
- 2005-03-10 AR ARP050100916A patent/AR048001A1/es unknown
-
2006
- 2006-08-15 IL IL177499A patent/IL177499A0/en unknown
- 2006-09-29 NO NO20064416A patent/NO20064416L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20064416L (no) | 2006-12-07 |
US20080161339A1 (en) | 2008-07-03 |
EP1725533A1 (en) | 2006-11-29 |
CA2558390A1 (en) | 2005-09-22 |
WO2005087744A8 (en) | 2006-10-26 |
WO2005087744A1 (en) | 2005-09-22 |
TW200540159A (en) | 2005-12-16 |
JP2007527900A (ja) | 2007-10-04 |
IL177499A0 (en) | 2006-12-10 |
KR20060124783A (ko) | 2006-12-05 |
AU2005221831A1 (en) | 2005-09-22 |
BRPI0508473A (pt) | 2007-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR048001A1 (es) | Hidroxi - 6 - fenilantridinas que contienen tio con actividad inhibitoria de pde4 y composiciones farmaceuticas que las contienen para el tratamiento de trastornos respiratorios. | |
PE20120357A1 (es) | Derivados de benzofurano | |
CY1118969T1 (el) | Ενωσεις πυριμιδινο-2-αμινης και η χρηση τους ως αναστολεις των κινασων jak | |
EA200970510A1 (ru) | Гетеромоноциклическое соединение и его применение | |
AR062409A1 (es) | Compuesto y composicion farmaceutica, utiles como agentes terapeuticos en el tratamiento, prevencion o mejoramiento de enfermedad o trastorno caracterizado por depositos o niveles de b-amiloide elevados o para inhibir o elucidar la enzima b-secretasa, y proceso para la preparacion del compuesto | |
BRPI0612888B8 (pt) | anilino-piridinotriazinas cíclicas como inibidoras de gsk-3, seus usos e composição farmacêutica, intermediário, seu uso e composição farmacêutica | |
ECSP099728A (es) | Compuestos amino-heterocíclicos | |
BRPI0616574A2 (pt) | derivado de sulfonamida tendo atividade antagonìstica de receptor de pgd2 | |
PE20121471A1 (es) | Derivados de sulfonamida heterociclicos utiles como inhibidores de mek | |
UY29301A1 (es) | Derivados amida | |
BRPI0513750A (pt) | 2-fenilamino-benzamidas-5-substituìdas como inibidoras de mek | |
AR053092A1 (es) | Compuestos derivados de acido fenoxiacetico y compuestos intermediarios de sintesis | |
AR071577A1 (es) | Pirazolo-pirimidinona para el tratamiento de trastornos del sistema nervioso central | |
AR083849A1 (es) | Antagonistas de mdm2 de espiro-oxindol | |
UY28578A1 (es) | Derivados de amida | |
EA201270666A1 (ru) | Соединения и фармацевтические композиции для снижения уровня мочевой кислоты | |
AR036032A1 (es) | Compuesto derivado de quinolina, composicion que lo comprende; uso del mismo en la fabricacion de medicamentos, proceso para prepararlo, y metodo para detectar y seleccionar un agente que module la actividad del mif | |
NI200300053A (es) | Derivados del tropano utiles en terapia. | |
PE20090370A1 (es) | Derivados de heterociclo fusionado como inhibidores de quinasa | |
PA8614301A1 (es) | Derivados de tropano | |
AR070487A1 (es) | Derivados de 3- metil- imidazo -( 1,2-b)- piridazina | |
EA200870360A1 (ru) | Бензимидазолы, обладающие активностью в отношении рецепторов м1, и их применение в медицине | |
DE602006006712D1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
AR057906A1 (es) | Derivados de pirimidona biciclicos sustituidos y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por la actividad anormal de gsk3beta. | |
BRPI0408591A (pt) | derivados de 6,7,8,9-tetrahidropirimido[1,2-a] pirimidin-4-ona 8-substituìda |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |